Document is current

Any future updates will be listed below

The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies

Crossref DOI link: https://doi.org/10.1007/s12325-017-0643-3

Published Online: 2017-11-13

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark